Geron GERN Product revenue, net — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Geron in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Geron's product revenue, net — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Geron's product revenue, net — total revenues?
- Geron (GERN) reported product revenue, net — total revenues of $51.77M in Q1 2026.
- How has Geron's product revenue, net — total revenues changed year-over-year?
- Geron's product revenue, net — total revenues increased by 31.3% year-over-year, from $39.44M to $51.77M.
- What does product revenue, net — total revenues mean?
- This metric represents the net revenue generated specifically from the commercial sale of pharmaceutical products, excluding income from licensing, milestones, or collaboration agreements. It serves as a key indicator of the company's transition from a clinical-stage research entity to a commercial-stage business. Tracking this figure allows investors to assess the market adoption and revenue-generating potential of the company's core therapeutic assets.